Approaches to planning treatment for patients with newly diagnosed chronic lymphocytic leukemia, as recommended by healthcare professionals from Memorial Sloan Kettering Cancer Center.
January 24th 2022
Susan O’Brien, MD, and Anthony Mato, MD, MSCE, describe their preferences for treating newly diagnosed chronic lymphocytic leukemia based on disease presentation and patient variables.
January 31st 2022
The rationale for investigating and using PI3K inhibitors to treat chronic lymphocytic leukemia.
Implications for treating chronic lymphocytic leukemia with small molecule combination regimens in the frontline setting.
Exciting novel-based treatment strategies being investigated in chronic lymphocytic leukemia.